Epileptic spasms in paediatric post-traumatic epilepsy at a tertiary referral centre

Jun T Park1, Harry T Chugani2

  • 1Division of Pediatric Epilepsy, Department of Pediatrics, Rainbow Babies & Children's Hospital, Case Western University School of Medicine, Cleveland, Ohio.

Insights

Epileptic spasms (ES) can occur after traumatic brain injury (TBI) in children. Non-accidental head trauma and infant TBI increase ES risk, often presenting with cognitive delay and encephalopathy.

Area of Science:

  • Pediatric Neurology
  • Neurotraumatology
  • Epileptology

Background:

  • Traumatic brain injury (TBI) is a significant cause of acquired epilepsy in children.
  • Epileptic spasms (ES) are a distinct seizure type, but their occurrence and mechanisms post-TBI are not well understood.
  • Understanding ES post-TBI is crucial for early diagnosis and intervention in pediatric populations.

Purpose of the Study:

  • To recognize epileptic spasms (ES) as a specific seizure type following traumatic brain injury (TBI) in infants and children.
  • To investigate the potential mechanisms of epileptogenesis contributing to ES after TBI.
  • To determine the incidence and clinical characteristics of ES in children with TBI.

Main Methods:

  • Retrospective electronic chart review of 321 pediatric patients at the Children's Hospital of Michigan (2002-2012).
  • Inclusion criteria: patients diagnosed with post-traumatic epilepsy (PTE).
  • Data collected: age at TBI, trauma mechanism, injury severity, EEG/neuroimaging, seizure semiology, and treatment outcomes.

Main Results:

  • Six out of 47 patients (12.8%) with PTE were diagnosed with ES, occurring 2 months to 2 years post-TBI.
  • All ES patients exhibited multifocal epileptiform discharges, cognitive delay, and epileptic encephalopathy.
  • The overall risk of PTE was 14.6%, with a specific risk of ES post-TBI at 1.8%. Non-accidental head trauma and severe TBI in infancy were identified as risk factors.

Conclusions:

  • Epileptic spasms represent a distinct seizure type following TBI in children, often associated with significant neurological comorbidities.
  • Non-accidental head trauma and TBI during infancy are significant risk factors for developing ES.
  • The pathophysiology may involve cortical abnormalities interacting with subcortical structures during critical maturation stages.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K